AZD6765 for Treatment Resistant Depression

Completed · Phase 2

Conditions studied: Depression

In brief

The purpose of this study is to determine whether treatment with AZD6765 will have an antidepressant effect with patients who have treatment resistant depression.

Key facts

Study ID

NCT00491686

Run by

AstraZeneca

People needed

34

Starts

2007-07-01

Expected to finish

2007-11-01

Last updated by the study team

2011-01-21

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Depression
• Inadequate response to an adequate course of antidepressants

You may not qualify if…

• Psychiatric disorder other than depression
• Pregnancy or lactation
• Current diagnosis of cancer

Where it is running

• Research Site — Glendale, California, United States
• Research Site — Hartford, Connecticut, United States
• Research Site — New Haven, Connecticut, United States
• Research Site — Wichita, Kansas, United States
• Research Site — Rockville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.